Gene patents are discoveries, not inventions and patenting
discoveries may hamper future innovations in developing cost-effective patient
care products and services. Banning gene patents may offer incredible
opportunities for innovations that can attract investments to create
sustainable entrepreneurial establishments and scientific jobs, which may be
significantly higher that gene patents alone can offer. In contrast, granting gene
patents may lead to innovation bottlenecks that favor fewer inventions,
restricted entrepreneurial initiatives, limited job growth, and non-competitive
monopoly. Read the full blog: http://www.sciclips.com/sciclips/blogArticle.do?id=1025&blog=Gene%20patents%20may%20hamper%20innovations%20in%20patient%20care
Wednesday, December 12, 2012
Subscribe to:
Posts (Atom)